Similarly to the 90-day readmission results, our 365-day analysis revealed that patients who were readmitted were more likely to have heart failure (95% CI 1.169-1.595, p-value < 0.05), HMG CoA reductase inhibitors (95% CI 1.049-1.364, p-value: 0.008), female gender (95% CI 1.088-1.388, p-value: 0.001), chronic kidney disease (95% CI 1.043-1.537, p-value: 0.017), ARBs (95% CI 0.699-0.986, p-value: 0.034). Here, HMGCR is linked to heart failure.